For FY27, incremental revenues are estimated at Rs 10-20 billion from India's branded formulations market, around Rs 45 billion from regulated markets like Canada and Brazil, and Rs 5-10 billion from emerging markets
So why does the person in the mirror look a little deflated, a little softer, a little less like the toned version of yourself you pictured when you started
"Furthermore, this [higher dose] would be considered 'off-label' use of these medications, and they are already difficult to get coverage for through insurance, so there could be a significant out-of-pocket cost for the patient," he added.What to know about GLP-1 drugs Glucagon-like peptide-1 receptor agonists (GLP-1s) medications work by mimicking a hormone in the body that helps regulate blood sugar levels and reduces hunger pangs
Ozempic is inspiring a new entry in dupe culture
Side effects of Qsymia are tingling sensations, taste changes, dry mouth, and constipation